Joint Formulary & PAD

Methotrexate - Atopic dermatitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral solution
  • Subcutaneous infusion
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Methotrexate
Indication :
Atopic dermatitis
Group Name :
Keywords :
dermatology, skin, atopic, dermatitis
Brand Names Include :
Important Information :

For adults see methotrexate -dematology indications

For severe atopic dermatitis in children from age 2 to 16 years under paediatric dermatology specialist only

Latest Additions Date From :
19 Nov 2025
Latest Additions Date To :
19 Dec 2025
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Jan 24 - RSFT DTC

Approved as Red for paediatric dermatology specialists only at RSFT DTC Jan 2024

Other Drugs

Below are listed other drugs that are used to treat Atopic dermatitis.